2Chang TC, Wu SL, Hsiao YL.TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellar domain of entire TSH receptor [J]. Clin Irmmunol Immunopathol, 1994,71 ( 1 ): 113 ,20.
3Fatourechi V,Pajouhi M,Fransway AF.Dermopathy of Graves disease (pretifial myxedema). Review of 150 cases [J]. Medicine( Baltimore), 1994,73(1):1 -7.
1Daumerie C, Ludgate M, Costagliola S, et al. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy [J]. Eur J Endocrinol, 2002, 146 (1): 35-8.
2Anderson CK, Miller OF. Triad of exophthahnos, pretibial myxedema,and acropachy in a patient with Graves' disease. J Am Acad Dermatol, 2003,48:970-972.
3Fatourechi V. Pretibial myxedema pathophysiology and treatment options. Am J Clin Dermatol,2005 ,6 :295-309.
5Schwartz KM, Fatourechi V, Ahmed DD, et al. Dermopathy of Graves' disease (pretibial myxedema) :long-term outcome. J Clin Endocrinol Metab ,2002,87:438-446.
6Katarzyna WS, Katarzyna KV, Krystyna O. The metabolism of glycosaminoglycans in the course of Graves' disease. Postepy Hig Med Dosw ,2006,60 : 184-191.
7Daumerie C,Ludgate M. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol,2002 ,146 :35-38.
8Cho S, Chol JH,Sung KJ,et al. Graves' disease presenting as elephantiasic pretibial myxedema and nodules of the hands. Int J Dermatol,2001,40 :276-277.
9Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med, 2005,118:706-714.
10Laura SW. Some lessons from a rare case of severe elephantiasic myxedema associated with subclinical thyroid disease. Endocrinol,2006 ,16 :245-247.
